Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity

MLA

Li, Xi, et al. “Synthesis, Biological Evaluation and Molecular Docking Studies of 3-(1,3-Diphenyl-1H-Pyrazol-4-Yl)-N-Phenylacrylamide Derivatives as Inhibitors of HDAC Activity.” Bioorganic & Medicinal Chemistry, vol. 20, no. 14, July 2012, pp. 4430–36. EBSCOhost, https://doi.org/10.1016/j.bmc.2012.05.031.

APA

Li, X., Liu, J.-L., Yang, X.-H., Lu, X., Zhao, T.-T., Gong, H.-B., & Zhu, H.-L. (2012). Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity. Bioorganic & Medicinal Chemistry, 20(14), 4430–4436. https://doi.org/10.1016/j.bmc.2012.05.031

Chicago

Li, Xi, Jia-Lin Liu, Xian-Hui Yang, Xiang Lu, Ting-Ting Zhao, Hai-Bin Gong, and Hai-Liang Zhu. 2012. “Synthesis, Biological Evaluation and Molecular Docking Studies of 3-(1,3-Diphenyl-1H-Pyrazol-4-Yl)-N-Phenylacrylamide Derivatives as Inhibitors of HDAC Activity.” Bioorganic & Medicinal Chemistry 20 (14): 4430–36. doi:10.1016/j.bmc.2012.05.031.